Skip to main content

Genetic Technologies Licenses IP to Conexio Genomics

NEW YORK (GenomeWeb News) – Genetic Technologies announced today it is licensing patents related to its non-coding DNA technology to Conexio Genomics.

Financial and other terms of the non-exclusive deal were not disclosed.

Based in Fremantle, Western Australia, Conexio develop genetic sequencing and mutation detection products and provides services in those areas.

The patents covering GTG's technology have been at the center of numerous lawsuits the Australian molecular diagnostic test development firm has filed in recent years. Last week, it announced it is suing Reproductive Genetics Institute alleging infringement of a patent covering the technology.

GTG has also previously sued other firms including Beckman Coulter, Gen-Probe, which is now part of Hologic, and Agilent Technologies. It has settled its legal disputes with other companies surrounding the technology, including GeneSeek, Navigenics, Hologic, and Eurofins.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.